Breaking

House Republicans split with Trump team over ‘very frustrating’ funding fight as shutdown looms
DOJ task force finds ‘numerous instances’ of anti-Christian government bias under Biden
Trump trashes Nadler on heels of Dem’s House retirement announcement: ‘One of the most disgusting Congressmen’
DAVID MARCUS: RFK Jr is right, nobody knows how many Americans died of COVID
Justice Barrett opens up about ‘awkward’ start on SCOTUS, shadow docket and more in forthcoming memoir
EXCLUSIVE: Franklin Graham praises VP Vance’s stand, critiques his ‘salty’ language in RFK Jr. defense
Loyal Ex-Biden aide says fateful debate against Trump was ‘overblown’ in closed-door House grilling
Trump signs order renaming Pentagon back to ‘Department of War’

Home
Features
- View All On Demos
Buy Now
Search for:

Investing

Radiopharm achieves Nasdaq listing of ADS

November 27, 2024

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Radiopharm achieves Nasdaq listing of ADS

Download the PDF here.

This post appeared first on investingnews.com

0

admin

Website

Related Posts

Québec Communities Vote “No” to La Loutre Graphite Mine

September 6, 2025

Purepoint Uranium Closes Final Tranche of $6 Million Private Placement

September 6, 2025

Locksley Resources

September 6, 2025

Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (535)
- Investing (1,919)
- Politics (2,280)
- Stocks (666)

Disclaimer: 2morrowgrowth.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2025 2morrowgrowth.com | All Rights Reserved

Top

Type above and press Enter to search. Press Esc to cancel.